The diagnostic evaluation, treatment, and prevention of allergic contact dermatitis in the new millennium

Journal of Allergy and Clinical Immunology

Volumn 105, Issue 3, 2000, Pages 409-420

  Belsito, Donald V ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

Allergic contact dermatitis; Clinical manifestations; Common allergens; Diagnostic evaluation; Immunoregulation; Prevention; Treatment

Indexed keywords

ASCOMYCIN; CONTACT ALLERGEN; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; ECZEMA; IMMUNOSUPPRESSIVE TREATMENT; PATCH TEST; PHOTOTHERAPY; PRIORITY JOURNAL; REVIEW; SKIN ALLERGY;

EID: 0034025318     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2000.104937     Document Type: Article

References (116)

1. 1. Jadassohn J. Zur Kenntnis der medikamentössen Dermatosen. In: Jarisch A, Neisser A, editors. Verhandlungen der Deutschen Dermatologischen Gesellschaft, V Kongress. Berlin: Julius Springer; 1895. p103-29.
2. 2. Belsito DV. Patch-testing: after 100 years, still the gold standard in diagnosing cutaneous delayed-type hypersensitivity. In: DeVries YL, editor. Regulatory control and standardization of allergenic extracts: the Eighth International Paul-Ehrlich-Seminar. Stuttgart (Germany): Gustav Fischer; 1997. p 195-202.
3. 3. Kieffer M. Nickel sensitivity: relationship between history and patch test reaction. Contact Dermatitis 1979;5:398-401.
4. 4. Association of Schools of Public Health and National Institutes for Occupational Safety and Health. Proposed national strategy for the prevention of leading work-related diseases and injuries, 2. Washington (DC): The Association; 1988. p 65-95.
5. 5. Von Pirquet C. Allergie. Berlin: Julius Springer; 1910.
6. 6. Bloch B, Steiner-Wourlisch A. Die willkurliche Erzeungung der Primeluberemfindlichkeit beim Menschen und ihre Bedeutung fur das Idiosyndrasieproblem. Arch Dermatol Syphilol 1926;152:283-303.
7. 7. Landsteiner K, Chase MW. Studies on the sensitization of animals with simple chemical compounds, IX: skin sensitization induced by injection of conjugates. J Exp Med 1941;73:431-8.
8. 8. Dupuis G, Benezra C. Allergic contact dermatitis to simple chemicals: a molecular approach. New York: Marcel Dekker; 1982.
9. 9. Marks JG, Belsito DV, DeLeo VA, et al. North American Contact Dermatitis Group patch test results - 1996-1998. Arch Dermatol. In press.
10. 10. deGroot AC. Patch testing: test concentrations and vehicles for 2800 allergens. Amsterdam: Elsevier; 1986.
11. 11. Sommer G, Parker D, Turk JL. Epicutaneous induction of hyporeactivity in contact sensitization: demonstration of suppressor cells induced by contact with 2,4-dinitrothiocyanatebenzene. Immunology 1975;29:517-25.
12. 12. Parker D, Long PV, Turk JL. A comparison of the conjugation of DNTB and other dinitrobenzenes with free protein radicals and their ability to sensitize or tolerize. J Invest Dermatol 1983;81:198-201.
13. 13. Katz DH, Davie JM, Paul WE, Benacerraf B. Carrier function in anti-hapten antibody responses, IV: experimental conditions for the induction of hapten-specific tolerance or for the stimulation of anti-hapten anamnestic responses by "non-immunogenic" hapten polypeptide conjugates. J Exp Med 1971;134:201-23.
14. 14. Nalefski EA, Rao A. Nature of the ligand recognized by a hapten- and carrier-specific, MHC-restricted T cell receptor. J Immunol 1993;150:3806-16.
15. 15. Belsito DV. Allergic contact dermatitis. In: Freedberg IM, et al, editors. Fitzpatrick's dermatology in general medicine. 5th ed. New York: McGraw-Hill; 1999. p 1447-61.
16. 16. Gaspari AA. Mechanisms of resolution of allergic contact dermatitis. Am J Contact Dermatitis 1996;7:212-9.
17. 17. Skog E. The influence of pre-exposure to alkyl benzene sulphonate detergent, soap and acetone on primary irritant and allergic eczematous reactions. Acta Derm Venereol (Stockh) 1958;38:1-14.
18. 18. Walker FB, Smith PD, Maibach HI. Genetic factors in human allergic contact dermatitis. Int Arch Allergy Appl Immunol 1967;32:453-62.
19. 19. Silvennoinen-Kassinen S, Ilonen J, Tiilikainen A, Karvonen J. No significant association between HLA and nickel contact sensitivity. Tissue Antigens 1979;14:459-61.
20. 20. Valsecchi R, Bontempelli M, Vicari O, Scudeller G, Cainelli T. HLA antigens and contact sensitivity. Arch Dermatol 1982;118:533-4.
21. 21. Silvennoinen-Kassinen S, Ikäheimo I, Tiilikainen A. TAP1 and TA2 genes in nickel allergy. Int Arch Allergy Immunol 1997;114:94-6.
22. 22. Olerup O, Emtestam L. Allergic contact dermatitis to nickel is associated with a Taq 1 HLA-DQA allelic restriction fragment. Immunogenetics 1988;28:310-3.
23. 23. Sulzberger MB. Hypersensitiveness to arsphenamine in guinea pigs. Arch Dermatol 1929;20:669-97.
24. 24. Chase MW. Inhibition of experimental drug allergy by prior feeding of the sensitizing agent. Proc Soc Exp Biol Med 1946;61:257-9.
25. 25. Elmets CA, Bergstresser PR, Tigelaar RF, Wood PJ, Streilein JW. Analysis of the mechanism of unresponsiveness produced by haptens painted on skin exposed to low dose ultraviolet radiation. J Exp Med 1983;158:781-94.
26. 26. Nossal GJ. Molecular and cellular aspects of immunologic tolerance. Eur J Biochem 1991;202:729-37.
27. 27. Mustain EL, Claman HN, Moorhead JW. Antibody-mediated regulation of T cell responses, I: characterization of a monoclonal antibody which specifically regulates contact hypersensitivity to DNFB in BALB/c mice. J Immunol 1986;136:4372-8.
28. 28. Guerder S, Flavell RA. Costimulation in tolerance and autoimmunity. Int Res Immunol 1995;13:135-46.
29. 29. Kwangsukstith C, Maibach HI. Effect of age and sex on the induction and elicitation of allergic contact dermatitis. Contact Dermatitis 1995;33:289-98.
30. 30. Belsito DV, Dersarkissian RM, Thorbecke GJ, Baer RL. Reversal by lymphokines of the age-related hyporesponsiveness to contact sensitization and reduced Ia expression on Langerhans cells. Arch Dermatol Res 1987;279:S76-80.
31. 31. Belsito DV, Possick LE. Age-related changes in allergic contact hypersensitivity: functional T cell deficiencies are primarily responsible. J Invest Dermatol 1988;90:546.
32. 32. Marcussen PV. Primary irritant patch-test reactions in children. Arch Dermatol 1963;87:378-82.
33. 33. Rietschel RL, Rosenthal LE, North American Contact Dermatitis Group. Standard patch test screening series used diagnostically in young and elderly patients. Am J Contact Dermatol 1990;1:53-5.
34. 34. Gonçalo S, Gonçalo M, Azenha A, et al. Allergic contact dermatitis in children: a multicenter study of the Portuguese Contact Dermatitis Group (GPEDC). Contact Dermatitis 1992;26:112-5.
35. 35. Strauss HW. Artificial sensitization of infants to poison ivy. J Allergy 1931;2:137-44.
36. 36. Schubert H, Prater E. Sexual differences in contact allergy. Boll Dermatol Allerg Professionale 1987;2:35-9.
37. 37. Baer RL, Gigli I. Allergic eczematous contact dermatitis. In: Fitzpatrick TB, et al, editors. Dermatology in general medicine. 2nd ed. New York: McGraw-Hill; 1979. p 512-9.
38. 38. Belsito DV. The pathophysiology of allergic contact hypersensitivity. Clin Rev Allergy 1989;7:347-79.
39. 39. Balato N, Patruno C, Lembo G, Cuccurullo FM, Ayala F. Effect of pentoxifylline on patch test response. Contact Dermatitis 1996;34:153.
40. 40. Belsito DV, Kerdel FA, Potozkin J, Soter NA. Cimetidine-induced augmentation of allergic contact hypersensitivity reactions in mice. J Invest Dermatol 1990;94:441-5.
41. 41. Belsito DV. A Sherlockian approach to contact dermatitis. Dermatol Clin 1999;17:705-13.
42. 42. Mizoguchi S, Setoyama M, Kanzaki T. Linear lichen planus in the region of the mandibular nerve caused by an allergy 10 palladium in dental metals. Dermatology 1998;196:268-70.
43. 43. Laine J, Kalimo K, Happonen RP. Contact allergy to dental restorative materials in patients with oral lichenoid lesions. Contact Dermatitis 1997;36:141-6.
44. 44. Koch P, Bahmer FA. Oral lichenoid lesions, mercury hypersensitivity and combined hypersensitivity to mercury and other metals: histologically proven reproduction of the reaction by patch testing with metal salts. Contact Dermatitis 1995;33:323-8.
45. 45. Dang M, Hsu S, Bernstein E. Lichen planus or lichenoid tattoo reaction? Int J Dermatol 1998;37:860-1.
46. 46. Amann U, Luger TA, Metze D. Lichenoid pseudolymphomatous tattooing reaction. Hautarzt 1997;48:410-3.
47. 47. Tresukosol P, Ophaswongse S, Kullavanijaya P. Cutaneous reaction to cosmetic lip tattooing. Contact Dermatitis 1997;36:176-7.
48. 48. Lombardi P, Campolmi P, Sertoli A. Lichenoid dermatitis caused by nickel salts? Contact Dermatitis 1983;9:520-1.
49. 49. Sharma VK, Mandal SK, Sethuraman G, Bakshi NA. Para-phenylenediamine-induced lichenoid eruptions. Contact Dermatitis 1999;41:40-1.
50. 50. Ancona A, Monroy F, Fernandez-Diez J. Occupational dermatitis from IPPD in tyres. Contact Dermatitis 1982;8:91-4.
51. 51. Brancaccio RR, Cockerell CJ, Belsito D, Ostreicher R. Allergic contact dermatitis from color film developers: clinical and hislologic features. J Am Acad Dermatol 1993;28:827-30.
52. 52. Morton CA, Garioch J, Todd P, Lamey PJ, Forsyth A. Contact sensitivity to menthol and peppermint in patients with intra-oral symptoms. Contact Dermatitis 1995;32:281-4.
53. 53. Addy JH. Red sea coral contact dermatitis. Int J Dermatol 1991;30:271-3.
54. 54. Lembo G, Balato N, Patruno C, Pini D, Ayala F. Lichenoid contact dermatitis due to aminoglycoside antibiotics. Contact Dermatitis 1987;17:122-3.
55. 55. Schirmer RH, Kalveram KJ, Kalveram CM, Siebert J, Kunze J. Chronic lichenoid dermatitis in sensitization to alpha amylase in a baker. Z Hautkrankh 1987;62:792-7.
56. 56. Parodi G, Guarrera M, Rebora A. Lichenoid photocontact dermatitis to musk ambrette. Contact Dermatitis 1987;16:136-8.
57. 57. Yasuda H, Kumakiri M, Miura Y, Tsuchiya K, Shiratori A. Primula dermatitis. Hokkaido Igaku Zasshi 1983;58:617-21.
58. 58. Epstein S. Contact dermatitis from neomycin due to dermal delayed (tuberculin-type) sensitivity. Dermatologies 1956;113:191.
59. 59. Oliver EA, Schwartz L, Warren L. Occupational leukoderma: preliminary report. JAMA 1939;113:927.
60. 60. Fisher AA. Allergic petechial and purpuric rubber dermatitis: the PPPP syndrome. Cutis 1974;14:25-7.
61. 61. Penagos H, Jimenez V, Fallas V, O'Malley M, Maibach HI. Chlorothalonil, a possible cause of erythema dyschromicum perstans (ashy dermatitis). Contact Dermatitis 1996;35:214-8.
62. 62. Foussereau J, Cavelier C, Protois JC, Sanchez M, Heid E. A case of erythema multiforme with allergy to isopropyl-p-phenylenediamine of rubber. Contact Dermatitis 1988;18:183.
63. 63. Wolf R, Dorfman B, Krakowski A. Quinidine induced lichenoid and eczematous photodermatitis. Dermatologica 1987;174:285-9.
64. 64. Daoud MS, Gibson LE, Pittelkow MR. Hydroxyurea dermopathy: a unique lichenoid eruption complicating long term therapy with hydroxyurea. J Am Acad Dermatol 1997;36:178-82.
65. 65. Perez-Roldan F, Olalquiaga-Loewe J, Tejedor-Jorge A, Goicoechea-Diezhandino M. Lichenoid dermatitis secondary to captopril. Rev Clin Esp 1992;191:501-2.
66. 66. Kauppinen K, Niemi KM, Salo OP. Cutaneous reactions to practolol: clinical and histopathological study. Ann Clin Research 1976;8:232-40.
67. 67. Roberts DL, Marks R. Skin reactions to carbamazepine. Arch Dermatol 1981;117:273-5.
68. 68. Cohen DE, Brancaccio RR. What is new in clinical research in contact dermatitis. Dermatol Clin 1997;15:137-48.
69. 69. Krasteva M, Kehren J, Sayag M, et al. Contact dermatitis. II: clinical aspects and diagnosis. Eur J Dermatol 1999;9:144-59.
70. 70. Adams RM. Occupational skin disease. 3rd ed. Philadelphia: WB Saunders; 1999.
71. 71. Berman B, Chen VL, France DS, Dotz WI, Petroni G. Anatomical mapping of epidermal Langerhans cell densities in adults. Br J Dermatol 1983;109:553-8.
72. 72. Freeman S. Shoe dermatitis. Contact Dermatitis 1997;36:247-51.
73. 73. White IR, Smith BG. Dental amalgam dermatitis. Br Dent J 1984;156:259-60.
74. 74. Veien NK, Hattel T, Justesen O, Norholm A. Oral challenge with metal salts, 1: vesicular patch-test-negative hand eczema. Contact Dermatitis 1983;9:402-6.
75. 75. Slavin RG. Unusual responses to contact allergens. Allergy Asthma Proc 1999;20:229-30.
76. 76. Belsito DV. Reacciones a los antibióticos locales. Mapfre Med 1998;9:31-6.
77. 77. Belsito DV. Allergic contact dermatitis to topical glucocorticosteroids. Cutis 1993;52:291-4.
78. 78. Sulzberger MB. The patch test: who should and should not use it and why. Contact Dermatitis 1975; 1:117-9.
79. 79. Epstein WL. The use test for contact hypersensitivity. Arch Dermatol Res 1982;272:279-81.
80. 80. Marks JG Jr, Moss JN, Parno JR, et al. Methylchloroisothiazolinone/methylisothiazolinone (Kathon CG) Biocide-United States multicenter study of human skin sensitization. Am J Contact Dermat 1990;1:157-61.
81. 81. Mitchell JC. Multiple concomitant positive patch test reactions. Contact Dermatitis 1977;3:315-20.
82. 82. Przybilla B, Burg G, Thieme C. Evaluation of the immune status in vivo by the 2,4 dinitro-1-chlorobenzene contact allergy time (DNCB-CAT). Dermatologica 1983;167:1-5.
83. 83. Belsito DV, Storrs FJ, Taylor JS, et al. Reproducibility of patch tests: a US multicenter study. Am J Contact Dermat 1992;3:193-200.
84. 84. Geier J, Gefeller O, Wiechmann K, Fuchs T. Patch test reactions at D4, D5 and D6. Contact Dermatitis 1999;40:119-26.
85. 85. Kimber I, Gerberick GF, Basketter DA. Thresholds in contact sensitization: theoretical and practical considerations. Food and Chem Toxicol 1999;37:553-60.
86. 86. White SI, Friedmann PS, Moss C, Simpson JM. The effect of altering area of application and dose per unit area on sensitization by DNCB. Br J Dermatol 1986;115:663-8.
87. 87. Rees JL, Friedmann PS, Matthews JN. The influence of area of application on sensitization by dinitrochlorobenzene. Br J Dermatol 1990;122:29-31.
88. 88. Heylings JR, Clowes HM, Cumberbatch M, et al. Sensitization to 2,4-dinitrochlorobenzene: influence of vehicle on absorption and lymph node activation. Toxicology 1996;109:57-65.
89. 89. Dearman RJ, Cumberbatch M, Hilton J, et al. Influence of dibutyl phthalate on dermal sensitization to fluorescein isothiocyanate. Fundam Appl Toxicol 1996;33:24-30.
90. 90. Cumberbatch M, Scott RC, Basketter DA, et al. Influence of sodium lauryl sulphate on 2,4-dinitrochlorobenzene induced lymph node activation. Toxicology 1993;77:181-91.
91. 91. James WD, Rosenthal LE, Brancaccío RR, Marks JG Jr. American Academy of Dermatology patch testing survey: use and effectiveness of this procedure. J Am Acad Dermatol 1992;26:991-4.
92. 92. Marks JG Jr, Belsito DV, DeLeo VA, et al. North American Contact Dermatitis Group patch test results for the detection of delayed-type hypersensitivity to topical allergens. J Am Acad Dermatol 1998;38:911-8.
93. 93. Cohen DE, Brancaccio R, Andersen D, Belsito DV. Utility of a standard allergen series alone in the evaluation of allergic contact dermatitis: a retrospective study of 732 patients. J Am Acad Dermatol 1997;36:914-8.
94. 94. Larsen W, Nakayama H, Fischer T, et al. A study of new fragrance mixtures. Am J Contact Dermat 1998;9:202-6.
95. 95. Basketter DA, Scholes EW, Kimber I. The performance of the local lymph node assay with chemicals identified as contact allergens in the human maximization test. Food Chem Toxicol 1994; 32:543-7.
96. 96. Kimber I, Hilton J, Dearman RJ, et al. An international evaluation of the murine local lymph node assay and comparison of modified procedures. Toxicology 1995;103:63-73.
97. 97. Cederbrant K, Hultman P, Marcusson JA, Tibbling L. In vitro lymphocyte proliferation as compared to patch test using gold, palladium and nickel. Int Arch Allergy Immunol 1997;112:212-7.
98. 98. Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) and the National Toxicology Program Center for the Evaluation of Alternative Toxicological Methods (NICEATM), National Toxicology Program. The murine local lymph node assay: a test method for assessing the allergic contact dermatitis potential of chemicals/compounds. Research Triangle Park (NC): The Committee; 1999. NIH Publication No.: 99-4494.
99. 99. Rietschel RL, Fowler JF Jr. Fisher's contact dermatitis. 4th ed. Baltimore: Williams & Wilkins; 1995.
100. 100. Guin JD. Practical contact dermatitis. New York: McGraw-Hill; 1995.
101. 101. Hogan DJ, Dannaker CJ, Maibach HI. Contact dermatitis: prognosis, risk factors, and rehabilitation. Semin Dermatol 1990;9:233-46.
102. 102. Pryce DW, Irvine D, English JSC, et al. Soluble oil dermatitis: a follow-up study. Contact Dermatitis 1989;21:28-38.
103. 103. Halbert AR, Gebauer KA, Wall LM. Prognosis of occupational chromate dermatitis. Contact Dermatitis 1992;27:2149.
104. 104. Lips R, Rast H, Elsner P. Outcome of job change in patients with occupational chromate dermatitis. Contact Dermatitis 1996;34:268-71.
105. 105. Mork NJ, Austad J. Short wave ultraviolet light (UVB) treatment of allergic contact dermatitis of the hands. Acta Derm Venereol (Stockh) 1983; 63:87-9.
106. 106. Bruynzeel DP, Boonk WJ, vanKetel WG. Oral psoralen photochemotherapy of allergic contact dermatitis of the hands. Derm Beruf Umwelt 1982;30:16-20.
107. 107. Funk JO, Maibach HI. Horizons in pharmacologic intervention in allergic contact dermatitis. J Am Acad Dermatol 1994;31:999-1014.
108. 108. Krasteva M, Nicolas JF. Eczéma de contact: perspectives thérapeutiques. Objectif Peau 1996;4:442-4.
109. 109. Enk AH. Allergic contact dermatitis: understanding the immune response and potential for targeted therapy using cytokines. Mol Med Today 1997;3:423-8.
110. 110. Warshawshki L, Mitchell JC, Storrs FJ. Allergic contact dermatitis from glyceryl monothioglycolate in hair dressers. Contact Dermatitis 1981;7:351-2.
111. 111. 4H™ chemical protection list, safety 4, A/S. Lyngby (Denmark); 1991.
112. 112. Castelli D, Colin L, Camel E, Ries G. Pretreatment of skin with a ginkgo biloba extract/sodium carboxymethyl-b-1,3-glucan formulation appears to inhibit the elicitation of allergic contact dermatitis in man. Contact Dermatitis 1998;38:123-6.
113. 113. Schamberg JF. Desensitization of persons against ivy poison. JAMA 1919;73:1213.
114. 114. Strickler A. The value of the toxin (antigen) of Rhus toxicodendron and Rhus venenata in the treatment and desensitization of patients with dermatitis venenata. JAMA 1923;80:1588-90.
115. 115. Kligman AM. Hyposensitization against rhus dermatitis. Arch Dermatol 1958;78:47-72.
116. 116. Marks JG Jr, Trautlein JJ, Epstein WL, Laws DM, Sicard OR. Oral hypersensitization to poison ivy and poison oak. Arch Dermatol 1987;123:476-8.